Editorial: is vedolizumab effective for perianal Crohn's disease?

被引：1
|
作者：
Ungar, Bella [1 ]
Kopylov, Uri [1 ]
机构：
[1] Tel Aviv Univ, Gastroenterol Inst, Sheba Med Ctr Tel Hashomer, Sackler Sch Med, Tel Aviv, Israel
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 51卷 / 09期
关键词：
FISTULAS;
D O I：
10.1111/apt.15688
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：912 / 913
页数：2
相关论文
共 50 条
  • [31] VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE
    Macaluso, F. S.
    Cappello, M.
    Crispino, F.
    Grova, M.
    Privitera, A. C.
    Piccillo, G.
    Magnano, A.
    Ferracane, C.
    Belluardo, N.
    Giangreco, E.
    Fries, W.
    Viola, A.
    Di Mitri, R.
    Mocciaro, F.
    Camilleri, S.
    Garufi, S.
    Renna, S.
    Casa, A.
    Maida, M.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S159 - S160
  • [32] Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn's Disease
    Macaluso, F. S.
    Cappello, M.
    Crispino, F.
    Grova, M.
    Privitera, A. C.
    Piccillo, G.
    Magnano, A.
    Ferracane, C.
    Belluardo, N.
    Giangreco, E.
    Fries, W.
    Viola, A.
    Di Mitri, R.
    Mocciaro, F.
    Camilleri, S.
    Garufi, S.
    Renna, S.
    Casa, A.
    Maida, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S320 - S320
  • [33] Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn's Disease: ENTERPRISE Study
    Schwartz, David A.
    Peyrin-Biroulet, Laurent
    Lasch, Karen
    Adsul, Shashi
    Danese, Silvio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : 1059 - +
  • [34] Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
    Macaluso, Fabio Salvatore
    Cappello, Maria
    Crispino, Federica
    Grova, Mauro
    Privitera, Antonino Carlo
    Piccillo, Giovita
    Magnano, Antonio
    Ferracane, Concetta
    Belluardo, Nunzio
    Giangreco, Emiliano
    Fries, Walter
    Viola, Anna
    Di Mitri, Roberto
    Mocciaro, Filippo
    Camilleri, Salvatore
    Garufi, Serena
    Renna, Sara
    Casa, Angelo
    Maida, Marcello
    Orlando, Ambrogio
    Dis, Sicilian Network Inflamatory Bowel
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (05) : 629 - 634
  • [35] Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn's disease
    Kadleckova, B.
    Podmanicky, D.
    Lipovska, A.
    Zelinkova, Z.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I470 - I470
  • [36] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
    Gerum Gashaw Gebeyehu
    Joseph Fiske
    Eleanor Liu
    Jimmy K. Limdi
    Giacomo Broglio
    Christian Selinger
    Violeta Razsanskaite
    Philip J. Smith
    Paul K. Flanagan
    Sreedhar Subramanian
    Digestive Diseases and Sciences, 2023, 68 : 1983 - 1994
  • [37] Management of perianal Crohn's disease
    Person B.
    Wexner S.D.
    Current Treatment Options in Gastroenterology, 2005, 8 (3) : 197 - 209
  • [38] Nonfistulizing Perianal Crohn's Disease
    Simon, Emily
    Steinhagen, Emily
    CLINICS IN COLON AND RECTAL SURGERY, 2024,
  • [39] Management of Perianal Crohn's Disease
    Parian, Alyssa M.
    Obi, Megan
    Fleshner, Phillip
    Schwartz, David A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (08): : 1323 - 1331
  • [40] Managing Perianal Crohn’s Disease
    Dawn M. Wiese
    David A. Schwartz
    Current Gastroenterology Reports, 2012, 14 (2) : 153 - 161
12345